Monashee Investment Management
Monashee Investment Management is a hedge fund.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Monashee Investment Management Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
7,816,140Website Global Rank
455Website Monthly Traffic
Twitter Followers
Description
Monashee Investment Management is a hedge fund.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2021 | Humacyte | PIPE | 175M |
| 4/2021 | Astranis | Series C | 250M |
| 9/2021 | BioAtla | Post-IPO Equity | 0 |
| 4/2022 | MoonLake Immunotherapeutics | Post-IPO Equity | 115M |
| 3/2021 | X4 Pharmaceuticals | Post-IPO Equity | 0 |
| 6/2021 | ATI Physical Therapy | Post-IPO Equity | 0 |
| 7/2022 | Gossamer Bio | Post-IPO Equity | 0 |
| 10/2021 | Better Therapeutics | Post-IPO Equity | 0 |
| 5/2021 | HiberCell | Series B | 0 |
| 6/2020 | Fulcrum Therapeutics | Post-IPO Equity | 0 |
| 2/2022 | Scipher Medicine | Series D | 0 |
| 11/2020 | SomaLogic | Series A | 0 |
| 1/2022 | AN2 Therapeutics | Series B | 80M |
| 12/2021 | Pardes Biosciences | Post-IPO Equity | 0 |
| 6/2021 | Quanta | Series D | 0 |
| 2/2021 | Nuvation Bio | Post-IPO Equity | 502M |
| 6/2021 | Turntide Technologies | Convertible Note | 225M |
| 7/2021 | Strata Oncology | Series C | 0 |
| 9/2021 | Garuda Therapeutics | Series A | 72M |
| 1/2022 | Korro Bio | Series B | 0 |
| 11/2021 | Quell Therapeutics | Series B | 0 |
| 6/2021 | Kindbody | Series C | 0 |
| 3/2021 | EGenesis | Series C | 0 |
| 3/2021 | Caribou Biosciences | Series C | 115M |
| 10/2021 | Skyryse | Series B | 0 |
| 6/2021 | Ribon Therapeutics | Series C | 0 |
| 11/2021 | HotSpot Therapeutics | Series C | 0 |
| 7/2022 | Gossamer Bio | Post-IPO Equity | 0 |
| 4/2022 | MoonLake Immunotherapeutics | Post-IPO Equity | 0 |
| 2/2022 | Scipher Medicine | Series D | 0 |
| 1/2022 | AN2 Therapeutics | Series B | 0 |
| 1/2022 | Korro Bio | Series B | 0 |
| 12/2021 | Pardes Biosciences | Post-IPO Equity | 0 |
| 11/2021 | HotSpot Therapeutics | Series C | 0 |
| 11/2021 | Quell Therapeutics | Series B | 0 |
| 10/2021 | Better Therapeutics | Post-IPO Equity | 0 |
| 10/2021 | Skyryse | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
